1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        APAC Acute Lung Injury Market – By Therapy

1.3.2        APAC Acute Lung Injury Market – By End User

1.3.3        APAC Acute Lung Injury Market– By Country

2.           Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           APAC Acute Lung Injury Market– Market Landscape

4.1         Overview

4.2         APAC PEST Analysis

4.3         Experts Opinion

5.           APAC Acute Lung Injury Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Respiratory Diseases

5.1.2        Rising Geriatric Population

5.2         Market Restraints

5.2.1        High Cost of Therapies

5.3         Market Opportunities

5.3.1        Technological Advancements by Market Players

5.4         Future Trends

5.4.1        Growing Pipeline Drugs

5.5         Impact Analysis

6.           Acute Lung Injury Market– APAC Analysis

6.1         APAC Acute Lung Injury Market Revenue Forecast and Analysis

7.           APAC Acute Lung Injury Market Analysis – By Therapy

7.1         Overview

7.2         APAC Acute Lung Injury Market Revenue Share, by Therapy (2021 and 2028)

7.3         Mechanical Ventilation

7.3.1        Overview

7.3.2        Mechanical Ventilation: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Fluid Management

7.4.1        Overview

7.4.2        Fluid Management: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Pharmacotherapy

7.5.1        Overview

7.5.2        Pharmacotherapy: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

7.6         Adjunctive Procedures

7.6.1        Overview

7.6.2        Adjunctive Procedures: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

8.           APAC Acute Lung Injury Market Analysis – By End User

8.1         Overview

8.2         APAC Acute Lung Injury Market Revenue Share, by End User (2021 and 2028)

8.3         Hospitals

8.3.1        Overview

8.3.2        Hospitals: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Ambulatory Surgery Centers

8.4.1        Overview

8.4.2        Ambulatory Surgery Centers: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Others

8.5.1        Overview

8.5.2        Others: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

9.           APAC Acute Lung Injury Market – Country Analysis

9.1         APAC: Acute Lung Injury Market

9.1.1        Overview

9.1.2        APAC: Acute Lung Injury Market, by Country, 2021 & 2028 (%)

9.1.2.1          China: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.1.1          China: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.1.2          China: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

9.1.2.1.3          China: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

9.1.2.2          Japan: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.2.1          Japan: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.2.2          Japan: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

9.1.2.2.3          Japan: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

9.1.2.3          India: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.3.1          India: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.3.2          India: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

9.1.2.3.3          India: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

9.1.2.4          South Korea: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.4.1          South Korea: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.4.2          South Korea: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

9.1.2.4.3          South Korea: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

9.1.2.5          Australia: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.5.1          Australia: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.5.2          Australia: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

9.1.2.5.3          Australia: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

9.1.2.6          Rest of APAC: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.6.1          Rest of APAC: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.6.2          Rest of APAC: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

9.1.2.6.3          Rest of APAC: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

10.        Impact Of COVID-19 Pandemic on APAC Acute Lung Injury Market

10.1      APAC: Impact Assessment of COVID-19 Pandemic

11.        Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      GlaxoSmithKline Plc

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Stemedica Cell Technologies, Inc

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Windtree Therapeutics, Inc.

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      ReAlta Life Sciences, Inc.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Angion

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

Table 1.             APAC Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

Table 2.             China: Acute Lung Injury Market, by Therapy– Revenue and Forecast to 2028 (USD Million)

Table 3.             China: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 4.             Japan: Acute Lung Injury Market, by Therapy– Revenue and Forecast to 2028 (USD Million)

Table 5.             Japan: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 6.             India: Acute Lung Injury Market, by Therapy– Revenue and Forecast to 2028 (USD Million)

Table 7.             India: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 8.             South Korea: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

Table 9.             South Korea: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 10.          Australia: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

Table 11.          Australia: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 12.          Rest of APAC: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

Table 13.          Rest of APAC: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 14.          Organic Developments Done by Companies

Table 15.          Inorganic Developments Done by Companies

Table 16.          Glossary of Terms

Figure 1.           APAC Acute Lung Injury Market Segmentation

Figure 2.           APAC Acute Lung Injury Market Segmentation, By Country

Figure 3.           APAC Acute Lung Injury Market Overview

Figure 4.           Mechanical Ventilation Segment Held the Largest Share of the Market in 2021

Figure 5.           India to Show Significant Growth During Forecast Period

Figure 6.           APAC PEST Analysis

Figure 7.           APAC Acute Lung Injury Market Impact Analysis of Driver and Restraints

Figure 8.           APAC Acute Lung Injury Market– Revenue Forecast and Analysis

Figure 9.           APAC Acute Lung Injury Market Revenue Share, by Therapy (2021 and 2028)

Figure 10.        APAC Mechanical Ventilation: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.        APAC Fluid Management: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        APAC Pharmacotherapy: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        APAC Adjunctive Procedures: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        APAC Acute Lung Injury Market Revenue Share, by End User (2021 and 2028)

Figure 15.        APAC Hospitals: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        APAC Ambulatory Surgery Centers: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        APAC Others: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        APAC: Acute Lung Injury Market, by Key Country – Revenue (2021) (USD Million)

Figure 19.        APAC: Acute Lung Injury Market, by Country, 2021 & 2028 (%)

Figure 20.        China: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

Figure 21.        Japan: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

Figure 22.        India: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

Figure 23.        South Korea: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

Figure 24.        Australia: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

Figure 25.        Rest of APAC: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

Figure 26.        Impact of COVID-19 Pandemic on APAC Country Markets